Select Category

Rheumatoid Arthritis Treatment in Dubai UAE

Go Back

Posted on by

Rheumatoid Arthritis Fast Facts

Early Diagnosis is Essential

There is now a need to identify patients with rheumatoid arthritis in earlier stages of disease and to treat early so as to avoid joint damage. In early stages of disease patients can test negative for the blood test called rheumatoid factor in upto 50% of cases, and in established disease negative tests occur in 20% of patients. Responding to the need for earlier diagnosis, we have seen the proliferation of “early arthritis clinics” where patients are typically seen with less than 12 months of symptoms and attempts are made to classify them as whether they are at risk for developing full blown rheumatoid arthritis, based on certain criteria. Certain diagnostic modalities, including ultrasound and MRI of small joints have been useful to detect early bony erosions which have not been apparent on x-rays.

A new blood test called anti CCP (cyclic citrullinated peptide) is sometimes useful in patients who have rheumatoid factor negative undifferentiated arthritis. The presence of anti-CCP in these patients predicts a higher likelihood of developing rheumatoid arthritis. In patients with established rheumatoid arthritis, the presence of CCP antibodies can indicate a poorer prognosis, signaling a need for earlier and more aggressive treatments.

Disease modifying drugs should be used as soon as diagnosis of rheumatoid arthritis is made. The traditional drugs have included methotrexate, sulfasalazine, hydroxychloroquine, and more recently, leflunomide.

Newer treatments now available:

Tumor necrosis factor (TNF) blockers: All three of the available TNF blockers (Humira, Enbrel, Remicade)have led to quantum clinical improvement over that obtained with methotrexate alone. Infections, such as non serious infections (coughs, colds) or reactivation of hidden or latent tuberculosis, can occur with use of these medications. Overall all of these medications are safe, work very well and the risks are low. In fact methotrexate as well as the newer anti TNF therapies have been shown to prolong the life span of patients with arthritis. Newe treatments such as Rituximab, Actemra, and Orencia are also in use in Dubai.

Dr. Humeira Badsha, Consultant Rheumatologist, in Dubai, located at Al Biraa Arthritis and Bone Clinic +971 348-7031

About Arthritis Center

This web site is run by an Arthritis Specialist based in Dubai, United Arab Emirates. On this site you will find news about the latest in arthritis, information about research results in the field, tips and information and diet and exercise, and much more.

More

Archives


Latest Blog

Using your genes to predict if you will respond to Rheumatoid arthritis therapy. (not available in Dubai, UAE at this time)

The ORBIT data “showed that patients who have seropositive rheumatoid arthritis are just as likely to respond to rituximab therapy when compared ...

Read More

Your nose can repair your knee arthritis? Not yet in Dubai!

Doctors might one day be able to harvest cells from patients’ noses to produce cartilage that can be transplanted into damaged knee joints, a sma...

Read More

Green tea to the rescue!

Green tea has always been hailed for its anti-inflammatory properties. But researchers at Washington State University (WSU) in Spokane have now ide...

Read More

This web site is run by an Arthritis Specialist based in Dubai, United Arab Emirates. On this site you will find news about the latest in arthritis, information about research results in the field, tips and information and diet and exercise, and much more.

More

Recent Comments